refludan and Arrhythmogenic-Right-Ventricular-Dysplasia

refludan has been researched along with Arrhythmogenic-Right-Ventricular-Dysplasia* in 1 studies

Other Studies

1 other study(ies) available for refludan and Arrhythmogenic-Right-Ventricular-Dysplasia

ArticleYear
Crosstalk between coagulation and complement activation promotes cardiac dysfunction in arrhythmogenic right ventricular cardiomyopathy.
    Theranostics, 2021, Volume: 11, Issue:12

    Topics: Adult; Animals; Arrhythmogenic Right Ventricular Dysplasia; Autoantibodies; Blood Coagulation; Complement Activation; Female; Heart Ventricles; Hirudins; Humans; Male; Mice, Knockout; Middle Aged; Myocardium; Recombinant Proteins; Thrombin

2021